Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2013; 19(2): 290-298
Published online Jan 14, 2013. doi: 10.3748/wjg.v19.i2.290
Table 1 Statistical analyses of the different IL28B genotypes and alleles in non-responder and sustained viral response patients n (%)
Non-responders (NR = 79)Responders (SVR = 87)Odds ratio95%CIP value
CC (n = 24)8 (33.3)16 (66.7)4.5751.376-7.8460.025
CT (n = 117)58 (49.6)59 (50.4)0.8580.538-1.4490.589
TT (n = 25)13 (52)12 (48)0.9780.758-1.7590.464
C (n = 165)74 (44.8)91 (55.2)1.6360.773-3.4650.198
T (n = 167)84 (50.3)83 (49.7)0.7980.598-1.3490.604
Table 2 Influence of cytomegalovirus infection on response rate to interferon combined therapy in chronic hepatitis C virus infected patients with IL28B CT genotype n (%)
HCV response to treatment (n =117)IL 28B genotype (CT) +ve CMV patients (n = 45)IL 28B genotype (CT) -ve CMV patients (n = 72)
NR (n = 59)32 (71)27 (38)
SVR (n = 58)13 (29)45 (62)